Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-05-22
2000-07-11
Stockton, Laura L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 544364, 5462761, A61K 314439, A61K 31497, C07D40104, C07D40114
Patent
active
060873817
ABSTRACT:
A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I ##STR1## wherein Q, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as described in the specification.
REFERENCES:
patent: 3254093 (1966-05-01), Huisgen et al.
patent: 3984431 (1976-10-01), Gueremy et al.
patent: 4000281 (1976-12-01), Beiler et al.
patent: 5134142 (1992-07-01), Matsuo et al.
patent: 5466823 (1995-11-01), Talley et al.
patent: 5559137 (1996-09-01), Adams et al.
patent: 5589439 (1996-12-01), Goto et al.
patent: 5756529 (1998-05-01), Isakson et al.
patent: 5972972 (1999-10-01), Mihelich et al.
Zheng-Nian Huang, "Synthesis and Biological Activities of 1-(substituted pyrazol-4-yl)-1,2,4-triazoles", Chemical Abstracts, vol. 124, No. 23, Abstract No. 317062d, 1996.
Chemical Abstracts, 13.sup.th Chemical Substance Index 1992-1996 , Book 51, pp. 546-555, RN 175977-84-1, 175977-75-0 on p. 546 and RN 175977-81-8 175977-72-7, 175977-83-0 and 175977-78-3 on p. 547.
Zhengming, Li et al., "Synthesis of Di-heterocyclic Compounds; Pyrazolylimidazoles And Isoxazolylimadazoles", Heteroatom. Chem., vol. 9, No. 3, pp. 317-320 (1998).
Zheng-Nian Huang, "The Reaction Of .alpha.-OXO-.alpha.-Triazolyketene Dithioacetal With Amines, Hydrazine And Cuanidine", Chinese Chemical Letters, vol. 5, No. 1, pp. 31-34, 1994.
Hanson Gunnar J.
Liao Shuyuan
G. D. Searle & Company
Stockton Laura L.
LandOfFree
Pyrazole derivatives as p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole derivatives as p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivatives as p38 kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-542798